Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Sinopharm Group Co. Ltd. (SHTDY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
10.11+0.20 (+2.02%)
At close: 03:51PM EDT
Advertisement
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Total Revenue
533,402,727
521,051,235
456,414,611
425,272,726
344,525,821
Cost of Revenue
488,281,848
477,000,627
416,091,300
387,741,423
313,297,729
Gross Profit
45,120,879
44,050,608
40,323,311
37,531,303
31,228,092
Operating Expense
23,008,936
22,609,333
20,539,551
19,027,991
15,473,950
Operating Income
17,758,347
21,441,275
19,783,760
18,503,312
15,754,142
Net Non Operating Interest Income Expense
-3,401,931
-3,402,869
-2,944,189
-3,137,424
-4,095,228
Pretax Income
17,289,887
17,003,162
15,598,096
13,759,810
12,207,940
Tax Provision
4,025,027
3,938,389
3,500,805
3,139,738
2,803,456
Net Income Common Stockholders
7,869,551
7,758,646
7,187,204
6,251,355
5,833,547
Diluted NI Available to Com Stockholders
7,869,551
7,758,646
7,187,204
6,251,355
5,833,547
Basic EPS
-
-
11.55
10.55
9.85
Diluted EPS
-
-
11.55
10.50
9.80
Basic Average Shares
-
-
622,259
593,931
593,526
Diluted Average Shares
-
-
622,259
594,331
594,331
Total Operating Income as Reported
19,996,954
19,711,976
17,759,975
16,136,744
15,396,806
Total Expenses
511,290,784
499,609,960
436,630,851
406,769,414
328,771,679
Net Income from Continuing & Discontinued Operation
7,869,551
7,758,646
7,187,278
6,252,537
5,835,842
Normalized Income
9,839,652
9,436,060
8,960,016
8,169,018
6,072,746
Interest Income
564,209
558,562
676,358
519,437
513,416
Interest Expense
3,444,856
3,756,835
3,424,756
3,442,507
4,157,253
Net Interest Income
-3,401,931
-3,402,869
-2,944,189
-3,137,424
-4,095,228
EBIT
21,053,771
20,759,997
19,022,852
17,202,317
16,365,193
EBITDA
25,094,594
-
-
-
-
Reconciled Cost of Revenue
488,281,848
477,000,627
416,091,300
387,741,423
313,297,729
Reconciled Depreciation
3,373,216
3,922,058
3,597,114
3,114,076
1,394,679
Net Income from Continuing Operation Net Minority Interest
7,869,551
7,758,646
7,187,278
6,252,537
5,835,842
Total Unusual Items Excluding Goodwill
-2,567,899
-2,182,996
-2,285,634
-2,483,132
-307,508
Total Unusual Items
-2,258,826
-2,182,996
-2,285,634
-2,483,132
-307,508
Normalized EBITDA
22,667,524
26,865,051
24,905,600
22,799,525
18,067,380
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-521,117
-505,582
-512,896
-566,651
-70,604
Advertisement
Advertisement